Esperion Therapeutics
ESPR
ESPR
131 hedge funds and large institutions have $218M invested in Esperion Therapeutics in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 20 closing their positions.
Holders
131
Holders Change
+9
Holders Change %
+7.38%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
36
Reduced
35
Closed
20
Calls
$10.3M
Puts
$2.4M
Net Calls
+$7.87M
Net Calls Change
+$6.54M
Top Buyers
1 |
AC
1
Armistice Capital
New York
|
$9.57M |
2 |
2
Renaissance Technologies
New York
|
$4.25M |
3 |
3
D.E. Shaw & Co
New York
|
$3.63M |
4 |
WCM
4
Whitefort Capital Management
New York
|
$2.65M |
5 |
5
Two Sigma Investments
New York
|
$6.98M |